ES2173673T3 - Mezcla grasa y agentes dieteticos o farmaceuticos que las contienen. - Google Patents

Mezcla grasa y agentes dieteticos o farmaceuticos que las contienen.

Info

Publication number
ES2173673T3
ES2173673T3 ES98966662T ES98966662T ES2173673T3 ES 2173673 T3 ES2173673 T3 ES 2173673T3 ES 98966662 T ES98966662 T ES 98966662T ES 98966662 T ES98966662 T ES 98966662T ES 2173673 T3 ES2173673 T3 ES 2173673T3
Authority
ES
Spain
Prior art keywords
fatty acids
dietetic
fat blend
contain
linolenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98966662T
Other languages
English (en)
Inventor
Gunther Sawatzki
Gunther Boehm
Gerhard Kohn
Sandra Farwer
Michael Kliem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Application granted granted Critical
Publication of ES2173673T3 publication Critical patent/ES2173673T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mezcla grasa constituida por los componentes que son seleccionados a partir del grupo constituido por aceites, grasas, lecitinas, ácidos grasos y sus sales, y ésteres, y que contienen ácidos grasos poliinsaturados, caracterizado porque los ácidos grasos ácido gamma-linolénico, ácido estearidónico, y ácido eicosapentaenoico ascienden conjuntamente a 10 hasta 500 mg/g de ácidos grasos totales y el ácido gamma-linolénico y el ácido eicosapentaenoico ascienden respectivamente a un 20 hasta un 50 % en peso, y elácido estearidónico asciende a un 15 hasta un 50 % en peso de la suma de estos tres ácidos grasos.
ES98966662T 1997-12-23 1998-12-22 Mezcla grasa y agentes dieteticos o farmaceuticos que las contienen. Expired - Lifetime ES2173673T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757414A DE19757414A1 (de) 1997-12-23 1997-12-23 Fettmischung

Publications (1)

Publication Number Publication Date
ES2173673T3 true ES2173673T3 (es) 2002-10-16

Family

ID=7853100

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98966662T Expired - Lifetime ES2173673T3 (es) 1997-12-23 1998-12-22 Mezcla grasa y agentes dieteticos o farmaceuticos que las contienen.

Country Status (14)

Country Link
US (1) US7045143B1 (es)
EP (1) EP1041896B1 (es)
JP (1) JP2001526908A (es)
CN (1) CN1091363C (es)
AT (1) ATE213391T1 (es)
AU (1) AU758079B2 (es)
BR (1) BR9814467A (es)
CA (1) CA2316298C (es)
DE (2) DE19757414A1 (es)
DK (1) DK1041896T3 (es)
ES (1) ES2173673T3 (es)
NO (1) NO316302B1 (es)
NZ (1) NZ505608A (es)
WO (1) WO1999033355A2 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
DE19914104A1 (de) * 1999-03-23 2000-09-28 Siegfried Seifert Verfahren zur Verbesserung der körperlichen Erscheinung eines Menschen unter Verabreichung einer Fett-Eiweiß-Diät
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
AU6232899A (en) * 1999-10-06 2001-05-10 Campina Melkunie B.V. Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
EP2275101A1 (en) * 2001-05-14 2011-01-19 Martek Biosciences Corporation Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses
WO2002092779A2 (en) * 2001-05-17 2002-11-21 Pilot Therapeutics, Inc. Method for enriching tissues in long chain polyunsaturated fatty acids
BR0308290A (pt) * 2002-03-08 2005-01-11 Monsanto Technology Llc Tratamento e prevenção de distúrbios inflamatórios
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
DE10361667A1 (de) * 2003-12-30 2005-07-28 Omega For Life Gmbh Neuartige Fettpulver
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1811867A2 (en) * 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
US7893106B2 (en) * 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
US20090318394A1 (en) * 2004-11-19 2009-12-24 Julie Nauroth Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
JP2008520739A (ja) 2004-11-19 2008-06-19 マーテック・バイオサイエンシーズ・コーポレーション 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製および使用方法
EP1964554A1 (en) * 2005-11-30 2008-09-03 Katry Inversiones, S.L. Lipid mixture and use thereof for the preparation of a product that is intended for enteral or oral administration
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
EP1983977A4 (en) * 2006-01-31 2011-11-30 Martek Biosciences Corp OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF
CN101466270A (zh) * 2006-04-11 2009-06-24 马泰克生物科学公司 包含长链多不饱和脂肪酸的食品及其制备方法
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
US20080089981A1 (en) * 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
CA2567879C (en) * 2006-11-14 2013-03-26 Thomas Greither Nutritional food oil compositions and methods of making same
GB2444896B (en) * 2006-12-18 2010-05-19 Nutraceuticals Ltd Compositions comprising polyunsaturated fatty acids
US20110190389A1 (en) * 2007-02-20 2011-08-04 Linda Arterburn Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
US8652508B2 (en) 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
CA2701179C (en) * 2007-10-04 2021-03-16 Nestec S.A. Compositions and methods for enhancing cognitive function
EP3153030B1 (en) * 2007-11-29 2019-03-27 Monsanto Technology LLC Meat products with increased levels of beneficial fatty acids
US20110027841A1 (en) * 2007-12-21 2011-02-03 Martek Biosciences Corporation Method for preparation of oxylipins
US20100266746A1 (en) * 2009-04-16 2010-10-21 Monsanto Technology Llc Spread formulations including stearidonic acid
IN2012DN00563A (es) * 2009-07-15 2015-06-12 Solae Llc
BR112012007166A2 (pt) * 2009-09-30 2017-05-02 Solae Llc "composição de gordura alimentícia, método de uso de ácido estearidônico para formar uma composição de gordura alimentícia,composições alimentícias, manteiga de nozes e metodo para usar ácido esteardônico para formar uma manteiga de nozes.
WO2011071365A1 (en) * 2009-12-07 2011-06-16 N.V. Nutricia Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding
WO2011091019A1 (en) * 2010-01-19 2011-07-28 University Of Tennessee Research Foundation Methods and compositions for treating and preventing parenteral nutrition associated liver disease
US8372465B2 (en) * 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
ES2674430T3 (es) 2010-12-29 2018-06-29 Abbott Laboratories Producto nutricional para mejorar la tolerancia, digestión y absorción de nutrientes liposolubles en un lactante, niño pequeño o niño
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
WO2012138212A1 (en) 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
US20150157048A1 (en) * 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US11419350B2 (en) 2016-07-01 2022-08-23 Corbion Biotech, Inc. Feed ingredients comprising lysed microbial cells
CN109527123A (zh) * 2018-12-14 2019-03-29 大连大学 一种对慢性肠炎具有改善作用的调和油
CN112891304B (zh) * 2020-10-14 2022-06-10 麦孚营养科技有限公司 一种高能量密度的脂肪乳剂及其制备方法和其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924607A1 (de) 1989-07-21 1991-01-24 Singer Peter Dr Sc Med Diaetetisches nahrungs- oder genussmittel
EP0457950B1 (fr) * 1990-05-23 1993-10-20 Societe Des Produits Nestle S.A. Utilisation de l'acide stéaridonique pour le traitement des maladies inflammatoires
GB9026648D0 (en) 1990-12-07 1991-01-23 Efamol Holdings Nutrition
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
AU673700B2 (en) * 1993-01-27 1996-11-21 Scotia Holdings Plc Triglycerides
CA2119000A1 (en) 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
ES2463815T3 (es) * 1996-03-26 2014-05-29 Dsm Ip Assets B.V. Agregado tardío de pufa en el transcurso del proceso de preparación de una leche maternizada
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
ES2179156T3 (es) * 1996-11-20 2003-01-16 Nutricia Nv Composicion nutricional que incluye grasas para el tratamiento del sindrome metabolico.
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung

Also Published As

Publication number Publication date
CA2316298C (en) 2008-11-18
EP1041896A2 (de) 2000-10-11
DE19757414A1 (de) 1999-07-01
DK1041896T3 (da) 2002-06-17
DE59803153D1 (de) 2002-03-28
EP1041896B1 (de) 2002-02-20
US7045143B1 (en) 2006-05-16
CA2316298A1 (en) 1999-07-08
NO20003265L (no) 2000-06-22
ATE213391T1 (de) 2002-03-15
WO1999033355A2 (de) 1999-07-08
AU758079B2 (en) 2003-03-13
BR9814467A (pt) 2000-10-10
NZ505608A (en) 2002-12-20
AU2416299A (en) 1999-07-19
CN1091363C (zh) 2002-09-25
NO316302B1 (no) 2004-01-12
JP2001526908A (ja) 2001-12-25
CN1282223A (zh) 2001-01-31
HK1033541A1 (en) 2001-09-07
WO1999033355A3 (de) 1999-09-16
NO20003265D0 (no) 2000-06-22

Similar Documents

Publication Publication Date Title
DK1041896T3 (da) Fedtblanding
DK1121115T4 (da) PUFA-tilskud
Foster et al. Borage oil in the treatment of atopic dermatitis
EP1296670B1 (en) Therapeutic combinations of fatty acids
EP0815735A3 (fr) Produit laitier diététiquement équilibré
US5059622A (en) Method for reducing blood pressure levels in hypertensive persons
ATE216227T1 (de) Phospholipide
KR940018091A (ko) 불포화 지방산을 포함하는 처방
JPH08500332A (ja) 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
JPH0716076A (ja) 喫煙者のための調製物
NO884494D0 (no) Isoton omega-3-fettsyreholdig fettemulsjon og anvendelse derav.
DE3570362D1 (en) Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
CA2147302A1 (en) A lipid composition for normalizing injury
Gottschlich et al. Fat kinetics and recommended dietary intake in burns
Peck Essential fatty acid deficiency in renal failure: can supplements really help?
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
JP2537645B2 (ja) 薬剤的活性を有する栄養組成物
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
Maki et al. Bioavailability of eicosapentaenoic and docosahexaenoic n‐3 polyunsaturated fatty acids in salmon patties compared with capsules
Olafsson et al. Dietary cod liver oil decreases arachidonic acid in rat gastric mucosa and increases stress-induced gastric erosions
Ling et al. Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet
JP2001064171A (ja) 脱共役蛋白質発現誘導剤
Reddy et al. Omega-3 Polyunsaturated fatty acids in the prevention of progression of chronic renal disease
Houston The Use of Fish Oil Supplements in Clinical Practice: A Review
Fonteh Addition of Eicosapentaenoic Acid to g-Linolenic Acid-Supplemented Diets Prevents Serum Arachidonic Acid Accumulation in Humans1

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1041896

Country of ref document: ES